Putative Effects of Obesity on Linear Growth and Puberty

Shlomit Shalitin1, Wieland Kiess2

  • 1The Jesse Z. and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Insights

Childhood obesity impacts growth and puberty. This review explores how hormones like leptin in obese children influence skeletal growth and pubertal timing.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Childhood obesity is a global epidemic.
  • Obesity involves genetic and environmental factors, impacting nutrition, growth, and weight regulation.
  • Excess adiposity in childhood affects growth and puberty, with obese children often showing accelerated skeletal maturation.

Purpose of the Study:

  • To review the complex interactions between childhood obesity and the processes of growth and puberty.
  • To examine the role of hormonal factors, such as insulin and leptin, in mediating these effects.
  • To explore the hypothesis that body fatness triggers neuroendocrine events leading to puberty onset.

Main Methods:

  • Literature review focusing on the relationship between childhood obesity, hormonal regulation, and pubertal development.
  • Analysis of studies investigating hormonal profiles (growth hormone, insulin, leptin, androgens) in obese children.
  • Examination of research on skeletal growth, epiphyseal maturation, and pubertal timing in relation to body mass index.

Main Results:

  • Obese children often exhibit accelerated epiphyseal growth plate maturation and earlier puberty onset, particularly girls.
  • Elevated levels of insulin and leptin are common in obese children, with leptin potentially acting as a skeletal growth factor.
  • Leptin receptors are present in key neuroendocrine and reproductive tissues, suggesting a direct role in pubertal development.

Conclusions:

  • Childhood obesity significantly influences linear growth and pubertal timing through complex hormonal mechanisms.
  • Leptin and androgens may play crucial roles in the accelerated pubertal development observed in obese children.
  • Understanding these interactions is vital for addressing the public health challenges posed by childhood obesity.

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.8K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
335
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259